[{"Assets_0_Q3_USD":943259000.0,"CIK":"1706431","CommonStockSharesConverted_0_Q3_shares":126991631.0,"CommonStockSharesOutstanding_0_Q3_shares":126991631.0,"Country":"United States","EarningsPerShareBasic_1_Q3_USD":-0.67,"EarningsPerShareBasic_3_Q3_USD":-1.66,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"3076942595.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-108889000.0,"NetIncomeLossConverted_1_Q3_USD":-84609000.0,"NetIncomeLossConverted_3_Q3_USD":-193016000.0,"OfficialName":"Vir Biotechnology Inc. Common Stock","RevenuesConverted_1_Q3_USD":1928000.0,"RevenuesConverted_3_Q3_USD":74634000.0,"SP500":"nan","Sector":"Health Care","StockholdersEquity_0_Q3_USD":812355000.0,"Ticker":"VIR","filed":"20201110","footnote":"nan","form":"10-Q","fp":"Q3","fy":"2020.0","name":"VIR BIOTECHNOLOGY, INC.","period":"20200930","qtrs":"1","uom":"USD"}]